Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Sleep Disordered Breathing
NCT01832532Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Apr 2013
- Primary completion
- Dec 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in obstructive sleep apnea (OSA), sponsored by Cincinnati Children's Hospital Medical Center. Started Apr 2013; status: completed.
02
Drugs
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT01832532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01832532.